Literature DB >> 8994663

Tracking and quantitation of retroviral-mediated transfer using a completely humanized, red-shifted green fluorescent protein gene.

R R Muldoon1, J P Levy, S R Kain, P A Kitts, C J Link.   

Abstract

We have developed murine retroviral vectors (RVs) containing an optimized green fluorescent protein (GFP) gene to study retroviral gene transfer and expression in living cells. We used the codon "humanized", "red-shifted" GFP gene, hGFP-S65T, a gain of function variant of the wild-type GFP from the jellyfish Aequorea victoria. We cloned the hGFP-S65T gene into the RV plasmid pLNCX (pLNChG65T). A stable amphotropic RV-producer cell line (VPC), designated LNChG65T VPC, was generated that exhibited bright fluorescence in greater than 95% of the cells. Human A375 melanoma cells and IGROV ovarian carcinoma cells transduced from LNCh-G65T VPC demonstrated high levels of fluorescence. The expression of a single integrated hGFP-S65T gene in eukaryotic cells provides a powerful tool to study gene transfer, expression and functional studies in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8994663     DOI: 10.2144/97221rr03

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  4 in total

1.  DNA methylation of helper virus increases genetic instability of retroviral vector producer cells.

Authors:  W B Young; G L Lindberg; C J Link
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Chimeric retroviral helper virus and picornavirus IRES sequence to eliminate DNA methylation for improved retroviral packaging cells.

Authors:  W B Young; C J Link
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

3.  Transient, nonlethal expression of genes in vertebrate cells by recombinant entomopoxviruses.

Authors:  Y Li; R L Hall; R W Moyer
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

Review 4.  Gene-marked autologous hematopoietic stem cell transplantation of autoimmune disease.

Authors:  R K Burt; M Brenner; W Burns; E Courier; G Firestein; B Hahn; H Heslop; C Link; H McFarland; M Roland; M Territo; G Tsokos; A Traynor
Journal:  J Clin Immunol       Date:  2000-01       Impact factor: 8.317

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.